From Invesbiofarm our industrial contract researchers are engaged in the development of an innovative formula based on hyaluronic acid and thermoresistant epidermal growth factor for the treatment of osteoarthritis and its clinical evaluation.
This research is possible thanks to the hiring of a researcher under the “Industrial Doctorates”, a grant for the training of doctors in companies. This grant corresponds to the file DIN2024-013583, financed by MICIU/AEI /10.13039/501100011033. From Invesbiofarm we reaffirm our commitment to science and PhD talent applied to pharmaceutical innovation.